Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 4321–4340 of 17,529 recalls

October 12, 2021· Lupin Pharmaceuticals Inc.

Recalled Item: Irbesartan Tablets USP

The Issue: CGMP Deviations: impurity N-nitrosoirbesartan detected in API

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 12, 2021· Lupin Pharmaceuticals Inc.

Recalled Item: Irbesartan Tablets USP

The Issue: CGMP Deviations: impurity N-nitrosoirbesartan detected in API

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 12, 2021· Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals

Recalled Item: Methocarbamol 500mg Tablet

The Issue: Labeling: Label Error on Declared Strength; Bottles labeled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardCompleted
Refund
October 12, 2021· Lupin Pharmaceuticals Inc.

Recalled Item: Irbesartan and Hydrochlorothiazide Tablets USP

The Issue: CGMP Deviations: impurity N-nitrosoirbesartan detected in API

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 12, 2021· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: AllerClear D-24 hr

The Issue: Failed Moisture Limits

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 12, 2021· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate

The Issue: Failed Moisture Limits

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 8, 2021· Lupin Pharmaceuticals Inc.

Recalled Item: Imipramine Pamoate Capsules 125 mg

The Issue: Out of specification result observed in a dissolution

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 5, 2021· A-S Medication Solutions LLC.

Recalled Item: Cetirizine hydrochloride

The Issue: Labeling: Not Elsewhere classified: Product was relabeled as

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
October 5, 2021· Dr. Reddy's Laboratories, Inc.

Recalled Item: Dr. Reddy's Ezetimibe and Simvastatin Tablets

The Issue: Failed Excipient Specifications; product manufactured using an excipient

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 5, 2021· Dr. Reddy's Laboratories, Inc.

Recalled Item: Dr. Reddy's Ezetimibe and Simvastatin Tablets

The Issue: Failed Excipient Specifications; product manufactured using an excipient

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 5, 2021· Dr. Reddy's Laboratories, Inc.

Recalled Item: Dr. Reddy's Ezetimibe and Simvastatin Tablets

The Issue: Failed Excipient Specifications; product manufactured using an excipient

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 5, 2021· Dr. Reddy's Laboratories, Inc.

Recalled Item: Dr. Reddy's Ezetimibe and Simvastatin Tablets

The Issue: Failed Excipient Specifications and Presence of Foreign Tablets/Capsules;

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 5, 2021· Dr. Reddy's Laboratories, Inc.

Recalled Item: Dr. Reddy's Ezetimibe and Simvastatin Tablets

The Issue: Failed Excipient Specifications; product manufactured using an excipient

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 5, 2021· Dr. Reddy's Laboratories, Inc.

Recalled Item: Omeprazole Delayed-Release Capsules

The Issue: CGMP Deviations: Customer complaint for the presence of

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 4, 2021· Akorn, Inc.

Recalled Item: Betaxolol Ophthalmic Solution

The Issue: Microbial Contamination of Sterile Products: Confirmed sterility failure

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 1, 2021· Bayer Healthcare Pharmaceuticals Inc.

Recalled Item: Tinactin (Tolnaftate 1%) POWDER SPRAY NET WT 133g (4.6 oz) can

The Issue: Chemical Contamination: presence of benzene

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
October 1, 2021· Bayer Healthcare Pharmaceuticals Inc.

Recalled Item: Tinactin (Tolnaftate 1%) LIQUID SPRAY NET WT150g (5.3 OZ) can

The Issue: Chemical Contamination: presence of benzene

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
October 1, 2021· Bayer Healthcare Pharmaceuticals Inc.

Recalled Item: Tinactin (Tolnaftate 1%) DEODORANT POWDER SPRAY NET WT 133g (4.6 OZ) can

The Issue: cGMP Deviations: manufactured at the same facility where

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
October 1, 2021· Bayer Healthcare Pharmaceuticals Inc.

Recalled Item: LOTRIMIN AF

The Issue: Chemical Contamination: presence of benzene

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
October 1, 2021· Bayer Healthcare Pharmaceuticals Inc.

Recalled Item: LOTRIMIN AF (Miconazole nitrate 2%) Deodorant Powder Spray NET WT

The Issue: cGMP Deviations: manufactured at the same facility where

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund